Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-6-30
pubmed:abstractText
Several studies suggested a causal link between AML1 gene rearrangements and both radiation-induced acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS). Fifty-three AML samples were analyzed for the presence of AML1 abnormalities using fluorescent in-situ hybridization (FISH) and reverse transcription polymerase chain reaction (RT-PCR). Of these patients, 24 had experienced radiation exposure due to the Chernobyl accident, and 29 were non-irradiated spontaneous AML cases and served as controls. AML1/ETO translocations were found in 9 of 29 spontaneous AML but only in 1 of 24 radiation-associated AML cases. This difference between translocation frequencies is statistically significant in the age-unstratified cohorts (p=0.015). Following age stratification, the difference becomes less pronounced but remains on borderline significance (p=0.053). AML1 mutation status was assessed in 5 clean-up workers at Chernobyl NPP with MDS, or AML following MDS, by direct sequencing of genomic DNA from the coding region (exon 3 through 8). In one patient who developed MDS following an acute radiation syndrome, a hexanucleotide duplication of CGGCAT in exon 8 was found, inserted after base position 1502. Our results suggest that AML1 gene translocations are infrequent in radiation-induced leukemogenesis but are consistent with the idea that radiation may contribute to the development of MDS through AML1 gene mutation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0449-3060
pubmed:author
pubmed:issnType
Print
pubmed:volume
46
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
249-55
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:15988144-Adult, pubmed-meshheading:15988144-Aged, pubmed-meshheading:15988144-Causality, pubmed-meshheading:15988144-Chernobyl Nuclear Accident, pubmed-meshheading:15988144-Core Binding Factor Alpha 2 Subunit, pubmed-meshheading:15988144-DNA Mutational Analysis, pubmed-meshheading:15988144-DNA-Binding Proteins, pubmed-meshheading:15988144-Female, pubmed-meshheading:15988144-Gene Frequency, pubmed-meshheading:15988144-Humans, pubmed-meshheading:15988144-Incidence, pubmed-meshheading:15988144-Leukemia, Myeloid, Acute, pubmed-meshheading:15988144-Male, pubmed-meshheading:15988144-Middle Aged, pubmed-meshheading:15988144-Myelodysplastic Syndromes, pubmed-meshheading:15988144-Neoplasms, Radiation-Induced, pubmed-meshheading:15988144-Power Plants, pubmed-meshheading:15988144-Proto-Oncogene Proteins, pubmed-meshheading:15988144-Radioactive Hazard Release, pubmed-meshheading:15988144-Risk Assessment, pubmed-meshheading:15988144-Risk Factors, pubmed-meshheading:15988144-Transcription Factors, pubmed-meshheading:15988144-Translocation, Genetic, pubmed-meshheading:15988144-Ukraine
pubmed:year
2005
pubmed:articleTitle
Aml1 gene rearrangements and mutations in radiation-associated acute myeloid leukemia and myelodysplastic syndromes.
pubmed:affiliation
Department of Haematology, Research Centre for Radiation Medicine, Kyiv, Ukraine. klymenko_sergiy@yahoo.co.uk
pubmed:publicationType
Journal Article, Clinical Trial, Controlled Clinical Trial, Research Support, Non-U.S. Gov't